People · Operator
Named in public records as an officer, director or promoter · active 2013–2023 · Other Technology, Energy / Climate, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| View, Inc | — | Other Technology | Growth/Late | $1.4B | $26.0B | 2013 |
| Natron Energy, Inc. | — | Energy / Climate | Series D+ | $255.4M | $1.7B | 2021 |
| Tarveda Therapeutics, Inc. | — | Biotechnology | Series B | $127.4M | $141.9M | 2020 |
Aymeric Sallin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Aymeric Sallin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Samir Kaul | 1 | 32 |
| Robert S Langer | 1 | 14 |
| Peter Barton Hutt | 1 | 14 |
| Gabriel Kra | 1 | 12 |
| Gary Dillabough | 1 | 10 |
| SVEN STROHBAND | 1 | 8 |
| FAHRI DINER | 1 | 7 |
| Brian Roberts | 1 | 7 |
| James Barrett | 1 | 6 |
| CYNTHIA RINGO | 1 | 6 |
| PIERRE LAMOND | 1 | 6 |
| Andrew Feldman | 1 | 5 |
| Dennis Ausiello | 1 | 4 |
| Nilesh Kumar | 1 | 4 |
| Omid Farokhzad | 1 | 4 |
| Harold Hughes | 1 | 3 |
| EDWIN M. KANIA | 1 | 3 |
| Omid C. Farokhzad | 1 | 3 |
| Robert S. Langer, Jr. | 1 | 3 |
| Michael Metzger | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.